For patients and caregivers

For patients and caregivers

Receiving a cancer diagnosis can feel overwhelming, and there is often a lot of information to understand and navigate. Speaking with your healthcare team about your biomarker testing and results can help you understand your diagnosis and what treatment options are available to you.

You have the right to know whether biomarker testing has been performed and understand what your results mean. Discussing these results with your care team can help you make more informed decisions about your care, including access to targeted therapies and clinical trials, and can also provide more information about your prognosis.

Patients and caregivers

Questions you might want to ask your doctor:

Questions you might want to ask your doctor:

  • Which biomarkers are relevant for my cancer?
  • Should I have biomarker, molecular, or pharmacogenomic testing?
  • Has my cancer been tested? What did the results show?
  • What are the benefits, risks and alternatives to precision medicine?
  • Is testing still useful if I’ve already started treatment?
  • Will results affect my treatment plan?
  • Will I need additional tests?
  • How is my data protected?
  • What are the costs, and will insurance cover them?
  • Are there treatments or clinical trials linked to my biomarkers?
  • What if my tumour doesn’t have a “targetable” mutation?

Take time to ask questions, understand your options, and make informed decisions about what is right for you together with your care team.

Could a clinical trial be an option for me?

Clinical trials are driving progress in cancer treatment. They offer patients the opportunity to access new therapies, sometimes years before they become standard treatment and widely available.

A clinical trial is a research study that tests new treatments or new ways of using existing treatments, aiming at finding options that are more effective, safer (with fewer side effects), and able to improve quality of life.

How can I find and join a clinical trial?

1. Start with your oncologist

Your oncologist is the best person to guide you. They understand your type of cancer, the biology of your tumour, and your overall health, allowing them to identify clinical trials that may be suitable for you.

2. Search for clinical trials in our database

You can also search for information online and register your interest in taking part in research. You can look for trials through online databases and registries. These often include studies based on specific tumour characteristics (biomarkers), such as MSI-H (microsatellite instability), KRAS mutations, or HER2-positive cancers.

3. Ask patient organisations or support groups

Patient organisations may be aware of ongoing trials, helping you understand eligibility criteria, and supporting you through the process.

4. Consider specialised oncology support services

Some specialised oncology consultancies often have deep connections in the research community and can pinpoint trials that are a perfect fit for your unique situation, navigate complex eligibility criteria, and in some cases, even helping arrange for you to participate closer to home.

What are the potential benefits of joining a clinical trial?

If you are eligible, taking part in a clinical trial may offer:

  • Access to innovative treatments: you may receive new therapies that are being developed but aren’t yet approved for doctors to prescribe and aren’t yet widely available
  • Close medical monitoring: participants are often carefully followed by a specialised healthcare team
  • The opportunity to contribute to research: your participation can help improve future cancer treatments and benefit other patients.

Keep in mind: not every clinical trial is suitable for every patient. Each study has specific eligibility criteria, and there may be risks as well as benefits. It is important to discuss all options carefully with your healthcare team before making a decision.

For individuals at risk of digestive cancer

Can biomarkers identify an inherited cancer risk?

Most digestive cancers are not inherited and occur by chance. However, some people inherit genetic changes that increase their lifetime risk of developing certain cancers. 
If there is a strong family history of digestive cancer or other related cancers, your healthcare team may recommend genetic counselling and germline genetic testing. These tests look for inherited gene alterations, rather than changes found only in the tumour.

Some inherited genetic conditions associated with digestive cancers include:

  • Lynch syndrome, which increases the risk of colorectal, gastric and several other cancers
  • CDH1 mutations, associated with hereditary diffuse gastric cancer
  • BRCA1 and BRCA2 mutations, which increase the risk of several cancers, including pancreatic cancer

Identifying these inherited changes may help:

  • Estimate your future cancer risk
  • Guide personalised screening and surveillance, including earlier or more frequent monitoring where appropriate
  • Support prevention strategies, including lifestyle modifications and, in some cases, medical or surgical risk-reducing interventions
  • Identify relatives who may also benefit from genetic counselling testing

Questions you may want to ask your healthcare team:

  • Does my family history increase my cancer risk?
  • Should I consider genetic counselling or testing?
  • Could my relatives also benefit from genetic testing?
  • How do I find a certified genetic counsellor?
  • What are the benefits and risks of testing?
  • What happens if I choose not to be tested?
  • What will the test results tell me?
  • How will results affect my care or future screening?
  • Could my results impact my family members?
  • Will I need additional tests?
  • How will my genetic and medical information be protected?
  • What are the costs of genetic counselling and testing, and will insurance cover them?

In order to facilitate the use of our website, we use cookies.

Please confirm if you accept our tracking cookies. When declining the cookies, you can continue visiting the website without sending data to third party services. Read our complete cookie statement here.